209 related articles for article (PubMed ID: 12453675)
1. Gamma-secretase inhibitors and Alzheimer's disease.
Roberts SB
Adv Drug Deliv Rev; 2002 Dec; 54(12):1579-88. PubMed ID: 12453675
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of gamma-secretase as a therapeutic approach to Alzheimer's disease.
Tomita T; Iwatsubo T
Drug News Perspect; 2004 Jun; 17(5):321-5. PubMed ID: 15334182
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.
Evin G; Sernee MF; Masters CL
CNS Drugs; 2006; 20(5):351-72. PubMed ID: 16696577
[TBL] [Abstract][Full Text] [Related]
4. Secretase as a target for Alzheimer's disease.
Wolfe MS
Curr Top Med Chem; 2002 Apr; 2(4):371-83. PubMed ID: 11966461
[TBL] [Abstract][Full Text] [Related]
5. APP, Notch, and presenilin: molecular pieces in the puzzle of Alzheimer's disease.
Wolfe MS
Int Immunopharmacol; 2002 Dec; 2(13-14):1919-29. PubMed ID: 12489805
[TBL] [Abstract][Full Text] [Related]
6. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
Pollack SJ; Lewis H
Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
[TBL] [Abstract][Full Text] [Related]
7. Beta-secretase (BACE) as a drug target for Alzheimer's disease.
Vassar R
Adv Drug Deliv Rev; 2002 Dec; 54(12):1589-602. PubMed ID: 12453676
[TBL] [Abstract][Full Text] [Related]
8. Secretase inhibitors and modulators for Alzheimer's disease treatment.
Tomita T
Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
[TBL] [Abstract][Full Text] [Related]
9. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
10. Potential novel targets for Alzheimer pharmacotherapy: I. Secretases.
Maiorini AF; Gaunt MJ; Jacobsen TM; McKay AE; Waldman LD; Raffa RB
J Clin Pharm Ther; 2002 Jun; 27(3):169-83. PubMed ID: 12081630
[TBL] [Abstract][Full Text] [Related]
11. gamma-Secretase inhibitors as molecular probes of presenilin function.
Wolfe MS
J Mol Neurosci; 2001 Oct; 17(2):199-204. PubMed ID: 11816793
[TBL] [Abstract][Full Text] [Related]
12. Gamma-secretase inhibitors for Alzheimer's disease: balancing efficacy and toxicity.
Barten DM; Meredith JE; Zaczek R; Houston JG; Albright CF
Drugs R D; 2006; 7(2):87-97. PubMed ID: 16542055
[TBL] [Abstract][Full Text] [Related]
13. gamma-Secretase as a therapeutic target in Alzheimer's disease.
Guardia-Laguarta C; Pera M; Lleó A
Curr Drug Targets; 2010 Apr; 11(4):506-17. PubMed ID: 20015011
[TBL] [Abstract][Full Text] [Related]
14. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1.
Esler WP; Kimberly WT; Ostaszewski BL; Diehl TS; Moore CL; Tsai JY; Rahmati T; Xia W; Selkoe DJ; Wolfe MS
Nat Cell Biol; 2000 Jul; 2(7):428-34. PubMed ID: 10878808
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.
Nunan J; Shearman MS; Checler F; Cappai R; Evin G; Beyreuther K; Masters CL; Small DH
Eur J Biochem; 2001 Oct; 268(20):5329-36. PubMed ID: 11606195
[TBL] [Abstract][Full Text] [Related]
16. Gamma-secretase: substrates and inhibitors.
Rochette MJ; Murphy MP
Mol Neurobiol; 2002 Aug; 26(1):81-95. PubMed ID: 12392058
[TBL] [Abstract][Full Text] [Related]
17. The presenilins in Alzheimer's disease--proteolysis holds the key.
Haass C; De Strooper B
Science; 1999 Oct; 286(5441):916-9. PubMed ID: 10542139
[TBL] [Abstract][Full Text] [Related]
18. Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease.
Wolfe MS; Xia W; Moore CL; Leatherwood DD; Ostaszewski B; Rahmati T; Donkor IO; Selkoe DJ
Biochemistry; 1999 Apr; 38(15):4720-7. PubMed ID: 10200159
[TBL] [Abstract][Full Text] [Related]
19. gamma-secretase as a therapeutic target for treatment of Alzheimer's disease.
Tomita T; Iwatsubo T
Curr Pharm Des; 2006; 12(6):661-70. PubMed ID: 16472155
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the development of gamma-secretase inhibitors.
Josien H
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):513-25. PubMed ID: 12197309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
